Jakub is an Assistant Research Professor at the University of Southern California. He also serves as the Executive Director of the Healthcare Markets Initiative at the USC Schaeffer Center, which focuses on innovative solutions for better quality and access in healthcare. Since 2019, he has served as a project manager of a $2.3-million NIH grant “Ensuring Access To Novel Alzheimer’s and Dementia Treatments”. Outside of USC, he has been a research consultant for the National Academies of Sciences, Engineering, and Medicine (NASEM) and a member of the International Pharmacoeconomics Collaboration on Alzheimer’s Disease (IPECAD). Jakub‘s interests include Alzheimer’s disease and the economics of aging, innovative payment for emerging therapies, incl. cell and gene therapies in oncology, neurology and cardiovascular disease, health system reform and the study of inequality, and resilience and preparedness in both healthcare and national security.
He previously worked at the RAND Corporation on issues related to national security, defense planning, and access to health care. Jakub holds a PhD in policy analysis from the Pardee RAND Graduate School, a master’s degree from Georgetown University, and an bachelor’s degree from the University of Economics, Prague.
Last edited in July, 2022.